2 reports

  • 7.2 Growing Incidence of Cancer Patients
  • POLAND - FORECAST FOR NUMBER OF PATIENT DIAGNOSED WITH CANCER (NUMBER), 2017 - 2022
  • Cancer
  • Poland
  • Forecast
  • Market Size
  • Felicitex Therapeutics Enters into Co-Development Agreement with Selvita
  • Selvita Raises USD0.1 Million in Private Placement of Shares

Felicitex' s target therapy areas comprise colorectal cancer, pancreatic cancer, non-small cell lung cancer and ovarian cancer.

  • Cancer
  • Healthcare
  • Pharmaceutical
  • Poland
  • Selvita S.A.